A Phase I Study of Intra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3)
Phase of Trial: Phase I
Latest Information Update: 30 Dec 2018
At a glance
- Drugs Artesunate (Primary)
- Indications Anal dysplasia; Anal intraepithelial neoplasia; HIV infections; Human papillomavirus infections
- Focus Therapeutic Use
- Acronyms ART-AIN
- 28 Jun 2018 Planned End Date changed from 31 Mar 2019 to 31 Mar 2020.
- 28 Jun 2018 Planned primary completion date changed from 31 Mar 2018 to 31 Jul 2019.
- 20 Apr 2017 Status changed from not yet recruiting to recruiting.